AKT1 and neuroblastoma: Neuropeptide Y receptor 5 antagonists inhibited the prosurvival actions induced by BDNF via the p44/p42 mitogen-activated protein kinase and phosphatidylinositol 3-kinase/Akt pathways, favored apoptosis, and sensitized resistant NB cells to chemotherapy [43,44].